151 related articles for article (PubMed ID: 33035545)
1. Morin hydrate loaded solid lipid nanoparticles: Characterization, stability, anticancer activity, and bioavailability.
Karamchedu S; Tunki L; Kulhari H; Pooja D
Chem Phys Lipids; 2020 Nov; 233():104988. PubMed ID: 33035545
[TBL] [Abstract][Full Text] [Related]
2. Amorphous nano morin outperforms native molecule in anticancer activity and oral bioavailability.
Jangid AK; Agraval H; Gupta N; Jain P; Yadav UCS; Pooja D; Kulhari H
Drug Dev Ind Pharm; 2020 Jul; 46(7):1123-1132. PubMed ID: 32469607
[TBL] [Abstract][Full Text] [Related]
3. Designing of fatty acid-surfactant conjugate based nanomicelles of morin hydrate for simultaneously enhancing anticancer activity and oral bioavailability.
Jangid AK; Agraval H; Gupta N; Yadav UCS; Sistla R; Pooja D; Kulhari H
Colloids Surf B Biointerfaces; 2019 Mar; 175():202-211. PubMed ID: 30530006
[TBL] [Abstract][Full Text] [Related]
4. Morin Hydrate Encapsulation and Release from Mesoporous Silica Nanoparticles for Melanoma Therapy.
Cunha C; Marinheiro D; Ferreira BJML; Oliveira H; Daniel-da-Silva AL
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375331
[TBL] [Abstract][Full Text] [Related]
5. Preparation, in vitro and in vivo evaluation of polymeric nanoparticles based on hyaluronic acid-poly(butyl cyanoacrylate) and D-alpha-tocopheryl polyethylene glycol 1000 succinate for tumor-targeted delivery of morin hydrate.
Abbad S; Wang C; Waddad AY; Lv H; Zhou J
Int J Nanomedicine; 2015; 10():305-20. PubMed ID: 25609946
[TBL] [Abstract][Full Text] [Related]
6. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of Chrysin-Phospholipid complex loaded solid lipid nanoparticles - storage stability and in vitro anti-cancer activity.
Komath S; Garg A; Wahajuddin M
J Microencapsul; 2018 Sep; 35(6):600-617. PubMed ID: 30557060
[TBL] [Abstract][Full Text] [Related]
8. Beta-carotene-Encapsulated Solid Lipid Nanoparticles (BC-SLNs) as Promising Vehicle for Cancer: an Investigative Assessment.
Jain A; Sharma G; Thakur K; Raza K; Shivhare US; Ghoshal G; Katare OP
AAPS PharmSciTech; 2019 Feb; 20(3):100. PubMed ID: 30721373
[TBL] [Abstract][Full Text] [Related]
9. Enhanced oral bioavailability and anticancer efficacy of fisetin by encapsulating as inclusion complex with HPβCD in polymeric nanoparticles.
Kadari A; Gudem S; Kulhari H; Bhandi MM; Borkar RM; Kolapalli VR; Sistla R
Drug Deliv; 2017 Nov; 24(1):224-232. PubMed ID: 28156161
[TBL] [Abstract][Full Text] [Related]
10. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability.
Sun J; Bi C; Chan HM; Sun S; Zhang Q; Zheng Y
Colloids Surf B Biointerfaces; 2013 Nov; 111():367-75. PubMed ID: 23856543
[TBL] [Abstract][Full Text] [Related]
11. Surface modification of solid lipid nanoparticles for oral delivery of curcumin: Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake.
Baek JS; Cho CW
Eur J Pharm Biopharm; 2017 Aug; 117():132-140. PubMed ID: 28412471
[TBL] [Abstract][Full Text] [Related]
12. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines.
Doktorovova S; Souto EB; Silva AM
Pharm Dev Technol; 2018 Jan; 23(1):96-105. PubMed ID: 28949267
[TBL] [Abstract][Full Text] [Related]
13. Solid lipid nanoparticles of anticancer drug andrographolide: formulation, in vitro and in vivo studies.
Parveen R; Ahmad FJ; Iqbal Z; Samim M; Ahmad S
Drug Dev Ind Pharm; 2014 Sep; 40(9):1206-12. PubMed ID: 23826860
[TBL] [Abstract][Full Text] [Related]
14. Development and characterization of Brigatinib loaded solid lipid nanoparticles: In-vitro cytotoxicity against human carcinoma A549 lung cell lines.
Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Alsaidan YSM; Alfaiz SA; Haque A; Az A; Alhazzani K
Chem Phys Lipids; 2020 Nov; 233():105003. PubMed ID: 33096096
[TBL] [Abstract][Full Text] [Related]
15. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
16. Baicalin encapsulating lipid-surfactant conjugate based nanomicelles: Preparation, characterization and anticancer activity.
Jangid AK; Agraval H; Rai DB; Jain P; Yadav UC; Pooja D; Kulhari H
Chem Phys Lipids; 2020 Nov; 233():104978. PubMed ID: 32991905
[TBL] [Abstract][Full Text] [Related]
17. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
[TBL] [Abstract][Full Text] [Related]
18. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
[TBL] [Abstract][Full Text] [Related]
19. Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats.
Zhang S; Wang J; Pan J
Drug Deliv; 2016 Nov; 23(9):3696-3703. PubMed ID: 27749105
[TBL] [Abstract][Full Text] [Related]
20. Improved tumor targeting and antitumor activity of camptothecin loaded solid lipid nanoparticles by preinjection of blank solid lipid nanoparticles.
Jang DJ; Moon C; Oh E
Biomed Pharmacother; 2016 May; 80():162-172. PubMed ID: 27133053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]